<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Waters Corporation — News on 6ix</title>
    <link>https://6ix.com/company/waters-corporation</link>
    <description>Latest news and press releases for Waters Corporation on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 20 Apr 2026 20:15:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/waters-corporation" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835d6e378dffbe2df121fd7.webp</url>
      <title>Waters Corporation</title>
      <link>https://6ix.com/company/waters-corporation</link>
    </image>
    <item>
      <title>Waters Corporation Schedules First Quarter 2026 Earnings Conference Call</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-schedules-first-quarter-2026-earnings-conference-call-10</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-schedules-first-quarter-2026-earnings-conference-call-10</guid>
      <pubDate>Mon, 20 Apr 2026 20:15:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 2, 2026, at midnight Eastern Time.</description>
    </item>
    <item>
      <title>Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-debuts-industry-first-extended-range-mals-detector-for-uhplcuplc-powering-rapid-characterization-of-large-molecules</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-debuts-industry-first-extended-range-mals-detector-for-uhplcuplc-powering-rapid-characterization-of-large-molecules</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio. Featuring 18 angles of detection, the omniDAWN Photometer is the first extended-range MALS detector for Ultra High Performance Liquid Chromatography (UHPLC) and Ultra Performance Liquid Chromatography (UPLC) workflows, delivering absolute molar mass and size measurements without compromising resolution or throughput.</description>
    </item>
    <item>
      <title>Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-announces-fda-clearance-of-the-most-comprehensive-at-home-cervical-cancer-screening-tool-the-onclarity-hpv-self-collection-kit-and-fda-approved-hpv-assay</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-announces-fda-clearance-of-the-most-comprehensive-at-home-cervical-cancer-screening-tool-the-onclarity-hpv-self-collection-kit-and-fda-approved-hpv-assay</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay with extended genotyping for at-home use, marking a significant milestone in expanding access to cervical cancer screening, and removing barriers that currently prevent many individuals from receiving routine screening.</description>
    </item>
    <item>
      <title>Waters Prices Offering of Senior Notes</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-prices-offering-of-senior-notes</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-prices-offering-of-senior-notes</guid>
      <pubDate>Wed, 18 Mar 2026 10:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) (the &quot;Company&quot; or &quot;Waters&quot;) today announced that it has priced an offering (the &quot;Offering&quot;) of $3.5 billion aggregate principal amount of the following senior notes issued by its subsidiary, Augusta SpinCo Corporation (&quot;Augusta&quot;):</description>
    </item>
    <item>
      <title>Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-flagship-aresg3-rheometer-sets-new-benchmark-for-data-quality-at-breakthrough-speed</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-flagship-aresg3-rheometer-sets-new-benchmark-for-data-quality-at-breakthrough-speed</guid>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <description>Pittcon 2026 Conference + Exposition -- Waters Corporation (NYSE: WAT) today launched the ARES-G3™ Rheometer, part of the TA Instruments product line. This next-generation rheometer delivers industry-leading speed paired with best-in-class data to accelerate materials research and product development. Capturing up to 25,000 data points per second (10x more than its predecessor) and cutting standard test times by up to 80% through fully integrated Fast Frequency Chirps, the ARES-G3 Rheometer addr</description>
    </item>
    <item>
      <title>Waters Corporation to Present at the TD Cowen Health Care Conference</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-to-present-at-the-td-cowen-health-care-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-to-present-at-the-td-cowen-health-care-conference</guid>
      <pubDate>Mon, 23 Feb 2026 21:45:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen Health Care Conference on Monday, March 2nd, 2026, at 11:10 AM Eastern Time.</description>
    </item>
    <item>
      <title>Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-introduces-next-generation-microflow-lc-columns-with-maxpeak-premier-technology-delivering-higher-sensitivity-with-lower-sample-and-solvent-usage</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-introduces-next-generation-microflow-lc-columns-with-maxpeak-premier-technology-delivering-higher-sensitivity-with-lower-sample-and-solvent-usage</guid>
      <pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) today launched 1 mm I.D. liquid chromatography (LC) columns with Waters&apos; MaxPeak™ Premier Technology for its ACQUITY™, BioResolve™, and GTxResolve™ Column brands. Significantly improving sensitivity while minimizing solvent and sample waste, the new microflow columns deliver high-quality results across bioanalysis, pharmaceutical discovery and development, and metabolomics, proteomics and lipidomics – all areas where both sample availability and time are limited.</description>
    </item>
    <item>
      <title>Waters Completes Combination with BD&apos;s Biosciences &amp; Diagnostic Solutions Businesses</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-completes-combination-bds-biosciences-134000420</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-completes-combination-bds-biosciences-134000420</guid>
      <pubDate>Mon, 09 Feb 2026 13:40:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) (&quot;Waters&quot;) today announced it has completed the previously announced combination with the Biosciences &amp; Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE: BDX) (&quot;BD&quot;). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies, and an industry-leading financial outlook. The Company also announced the appointment of Claire M. Fraser, Ph.D., to its Board of Directors (the &quot;Waters Board&quot;), increas</description>
    </item>
    <item>
      <title>BD Completes Combination of Biosciences &amp; Diagnostic Solutions Business with Waters Corporation</title>
      <link>https://6ix.com/company/waters-corporation/news/bd-completes-combination-of-biosciences-and-diagnostic-solutions-business-with-waters-corporation</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/bd-completes-combination-of-biosciences-and-diagnostic-solutions-business-with-waters-corporation</guid>
      <pubDate>Mon, 09 Feb 2026 13:40:00 GMT</pubDate>
      <description>BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD&apos;s Biosciences &amp; Diagnostic Solutions business and the combination of the business with Waters Corporation (NYSE: WAT).</description>
    </item>
    <item>
      <title>Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-nyse-wat-reports-113000419</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-nyse-wat-reports-113000419</guid>
      <pubDate>Mon, 09 Feb 2026 11:30:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT), today announced its financial results for the fourth quarter and full year 2025.</description>
    </item>
    <item>
      <title>Waters Shareholders Approve Combination with BD&apos;s Biosciences &amp; Diagnostic Solutions Business</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-shareholders-approve-combination-bds-142500452</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-shareholders-approve-combination-bds-142500452</guid>
      <pubDate>Tue, 27 Jan 2026 14:25:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) (the &quot;Company&quot; or &quot;Waters&quot;) today announced that, at the Company&apos;s Special Meeting of Shareholders (the &quot;Special Meeting&quot;) held today, Waters shareholders overwhelmingly voted to approve the issuance of shares of Waters common stock to shareholders of Becton, Dickinson and Company (NYSE: BDX) (&quot;BD&quot;) in connection with the proposed combination of BD&apos;s Biosciences &amp; Diagnostic Solutions business with Waters.</description>
    </item>
    <item>
      <title>Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-schedules-fourth-quarter-180000186</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-schedules-fourth-quarter-180000186</guid>
      <pubDate>Tue, 20 Jan 2026 18:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) will hold its Q4 2025 financial results conference call on Thursday, February 12th, 2026 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 12, 2026, at midnight Eastern Time.</description>
    </item>
    <item>
      <title>Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-present-44th-annual-160000302</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-present-44th-annual-160000302</guid>
      <pubDate>Tue, 23 Dec 2025 16:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026 at 2:15 PM Pacific Time (5:15 PM Eastern Time).</description>
    </item>
    <item>
      <title>Waters Corporation to Present at the Jefferies Global Healthcare Conference in London</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-present-jefferies-global-190000250</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-present-jefferies-global-190000250</guid>
      <pubDate>Tue, 11 Nov 2025 19:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 18th, 2025, at 2:30 PM Greenwich Mean Time (9:30 AM Eastern Time).</description>
    </item>
    <item>
      <title>Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-boosts-lab-productivity-sample-130000520</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-boosts-lab-productivity-sample-130000520</guid>
      <pubDate>Tue, 11 Nov 2025 13:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) today announced the launch of its Charged Aerosol Detector (CAD) specifically designed for use with Waters Empower Software, the world&apos;s most trusted chromatography data system (CDS). Waters is the global market leader in chromatography software solutions for regulatory filings, as Empower Software is used to submit data for approximately 80% of novel drugs to regulatory authorities.2</description>
    </item>
    <item>
      <title>Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-nyse-wat-reports-110000592</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-nyse-wat-reports-110000592</guid>
      <pubDate>Tue, 04 Nov 2025 11:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT), today announced its financial results for the third quarter of 2025.</description>
    </item>
    <item>
      <title>Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-launches-charge-detection-mass-120000028</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-launches-charge-detection-mass-120000028</guid>
      <pubDate>Mon, 13 Oct 2025 12:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterization for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology. With the rapid growth of cell and gene therapies, mRNA, and complex protein therapeutics, scientists face significant challenges in analyzing increasingly large and heterogeneous drug modalities – yet existing tools are limited</description>
    </item>
    <item>
      <title>Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-schedules-third-quarter-160000671</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-schedules-third-quarter-160000671</guid>
      <pubDate>Wed, 01 Oct 2025 16:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) will hold its Q3 2025 financial results conference call on Tuesday, November 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 2nd, 2025, at midnight Eastern Time.</description>
    </item>
    <item>
      <title>Waters Corporation to Present at the Wells Fargo Healthcare Conference</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-present-wells-fargo-201000057</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-present-wells-fargo-201000057</guid>
      <pubDate>Tue, 26 Aug 2025 20:10:00 GMT</pubDate>
      <description>Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference on Thursday, September 4th, 2025, at 9:30 AM Eastern Time.</description>
    </item>
    <item>
      <title>Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/waters-corporation/news/waters-corporation-nyse-wat-reports-100000483</link>
      <guid isPermaLink="true">https://6ix.com/company/waters-corporation/news/waters-corporation-nyse-wat-reports-100000483</guid>
      <pubDate>Mon, 04 Aug 2025 10:00:00 GMT</pubDate>
      <description>Waters Corporation (NYSE: WAT), today announced its financial results for the second quarter of 2025.</description>
    </item>
  </channel>
</rss>